SCIEX

Activities: Analysis

Trending Articles

  1. Poolbeg Pharma trial to feature in groundbreaking cancer immunotherapy-induced CRS research programme Poolbeg will act as the lead business partner, alongside Johnson & Johnson and other partners, on the University of Manchester and The Christie NHS Foundation Trust research...
  2. Manufacturing Chemist Stand Side with Piramal Pharma Solutions We discover what exhibitors at CPHI 2025 are showcasing LIVE!
  3. SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
  4. One in four European pharma companies at risk of regulatory breaches according to NSF research The independent survey exposed significant gaps in quality systems, supply chain oversight and data integration, just as EU GMP regulations continue to tighten
  5. IWK introduces machine to produce 100% cardboard blister packaging CABLIblue 870 features innovative “card-to-card” technology for recyclable, fiber-based blisters

Upcoming event

From powder to granules: a deep dive into wet granulation methods

14 January 2026 | Virtual See all

Related Content

Research & Development

Veloxity Labs acquires SCIEX mass spectrometer, the ZenoTOF 8600 System, to accelerate peptide and complex bioanalysis

Veloxity Labs, a bioanalytical CRO built for programmes that need speed with purpose, has announced the acquisition of the ZenoTOF 8600 system from SCIEX, a global leader in life science analytical technologies
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

The long and short of it: a new way to analyse ultrashort-, short- and long-chain PFAS simultaneously (part II)

In Part II, one LC-MS/MS method “to detect them all” is introduced and the author, Craig Butt, Senior Manager, Applied Markets, Global Technical Marketing at SCIEX, looks at ways to streamline compliance with evolving global regulations
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

The long and short of it: a new way to analyse ultrashort-, short- and long-chain PFAS simultaneously (part I)

SCIEX PFAS expert, Craig Butt (pictured), explores innovative methods that enable the rapid, sensitive detection and monitoring of ultrashort-, short- and long-chain PFAS in complex environmental matrices such as air and seawater
Drug Delivery

The SCIEX BioPhase 8800 uses native fluorescence detection for protein-based CE assays

SCIEX, a global leader in life science analytical technologies, launches new native fluorescence detection on the BioPhase 8800 system
Analysis

SCIEX appoints Chris Hagen as President

SCIEX names new President as it expands footprint in analytical biotech
Drug Delivery

Sciex launches the Zenotof 7600+ system at HUPO 2024

New system features cutting-edge data acquisition and strategic collaborations to enhance proteomics
Research & Development

Improving the analysis of RNA medicines: what to expect in 2024

In vitro transcribed (IVT) RNA development has advanced since the first messenger RNA (mRNA) vaccines to prevent COVID-19 entered the market in 2020. Now the focus of similar drug candidates is on other prophylactic vaccines to prevent infectious diseases, including influenza and respiratory syncytial virus (RSV), and therapeutic drugs that might soon be used to treat cancer and other diseases
Subscribe now